MiMedx Group announced that Tom Koob, PhD, chief scientific officer of the company, will present at the Stem Cell Meeting on the Mesa on Oct. 7.
The Stem Cell Meeting on the Mesa, held in La Jolla, Calif., brings together opinion leaders, senior executives and decision-makers in the regenerative medicine and advanced therapies industry and the scientific community. Dr. Koob has published more than 125 biomedical and biological articles and 12 book chapters. He is also listed as an inventor on more than 40 issued and pending patents.
MiMedx is a developer, processor and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.
More articles on devices:
Is Orthofix still a good bet? These investors think so — 5 things to know
Medtronic may make changes on Covidien deal after all
SI-BONE expands European presence — 5 things to know